Serum soluble urokinase plasminogen activator receptor and early stage of diabetic kidney disease in patients with type 2 diabetes

被引：0
|
作者：
Wang, Tao [1 ]
机构：
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Nanjing, Jiangsu, Peoples R China
来源：
DIABETES-METABOLISM RESEARCH AND REVIEWS | 2018年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
961969
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Soluble urokinase-type plasminogen activator receptor (SuPAR) in patients with Parkinson's disease
    Witek, N.
    Joyce, J.
    Hawkins, J.
    Liu, Y.
    Ouyang, B.
    Patel, R.
    Borgia, J.
    Reiser, J.
    Hall, D.
    MOVEMENT DISORDERS, 2021, 36 : S460 - S460
  • [22] Role of Soluble Urokinase-Type Plasminogen Activator Receptor in Cardiovascular Disease
    Anis Ismail
    Salim S. Hayek
    Current Cardiology Reports, 2023, 25 : 1797 - 1810
  • [23] Role of Soluble Urokinase-Type Plasminogen Activator Receptor in Cardiovascular Disease
    Ismail, Anis
    Hayek, Salim S.
    CURRENT CARDIOLOGY REPORTS, 2023, 25 (12) : 1797 - 1810
  • [24] A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease
    Spinale, Joann M.
    Mariani, Laura H.
    Kapoor, Shiv
    Zhang, Jidong
    Weyant, Robert
    Song, Peter X.
    Wong, Hetty N.
    Troost, Jonathan P.
    Gadegbeku, Crystal A.
    Gipson, Debbie S.
    Kretzler, Matthias
    Nihalani, Deepak
    Holzman, Lawrence B.
    KIDNEY INTERNATIONAL, 2015, 87 (03) : 564 - 574
  • [25] Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes
    Theilade, S.
    Lyngbaek, S.
    Hansen, T. W.
    Eugen-Olsen, J.
    Fenger, M.
    Rossing, P.
    Jeppesen, J. L.
    JOURNAL OF INTERNAL MEDICINE, 2015, 277 (03) : 362 - 371
  • [26] Soluble Urokinase-Type Plasminogen Activator Receptor Levels in Patients With Schizophrenia
    Nielsen, Jimmi
    Roge, Rasmus
    Pristed, Sofie Gry
    Viuff, Anne Grethe
    Ullum, Henrik
    Thorner, Lise Wegner
    Werge, Thomas
    Vang, Torkel
    SCHIZOPHRENIA BULLETIN, 2015, 41 (03) : 764 - 771
  • [27] Clinical value of soluble urokinase type plasminogen activator receptors in chronic kidney disease
    Ahmed, Reem M.
    Khalil, Mona A.
    Ibrahim, Amal H.
    Eid, Hanaa M.
    Abdelbasset, Walid Kamal
    Soliman, Gaber S.
    MEDICINE, 2019, 98 (38)
  • [28] Soluble urokinase-type plasminogen activator receptor in sickle cell disease-associated chronic kidney disease
    Afangbedji, Nowah
    Kumari, Namita
    Diaz, Sharmin
    Wen, Fayuan
    Taylor, James G.
    Nekhai, Sergei
    Jerebtsova, Marina
    BLOOD ADVANCES, 2023, 7 (09) : 1854 - 1857
  • [29] The Role of Serum Soluble Urokinase-Type Plasminogen Activator Receptor in Stable Chronic Obstructive Pulmonary Disease
    Can, Ummugulsum
    Guzelant, Asuman
    Yerlikaya, Fatma Humeyra
    Yosunkaya, Sebnem
    JOURNAL OF INVESTIGATIVE MEDICINE, 2014, 62 (07) : 938 - 943
  • [30] Soluble urokinase plasminogen activator receptor in type 1 diabetic children, relation to vascular complications
    Sherif, Eman Mounir
    Abd El Maksood, Abeer Ahmed
    Youssef, Omneya Ibrahim
    El-Din, Nouran Yousef Salah
    Khater, Ola Khaled Mohamed
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2019, 33 (09) : 628 - 633
12345